TORONTO--(BUSINESS WIRE)--Alpha Cancer Technologies Inc. (ACT) a biopharmaceutical company focused on developing and commercializing targeted immuno-oncology and immunology therapies based on its ...

Doctors often monitor tumor markers in the blood to help diagnose and treat liver cancer. Alpha-fetoprotein (AFP) is the most common tumor marker that doctors monitor. Tumor markers, also called ...

Former US president Joe Biden's prostate cancer is likely too advanced to be cured but treatment could control the spread of the disease for years, experts told AFP. The revelation late Sunday that ...

Serum alpha-fetoprotein (AFP) is the current standard of care and only approved biomarker for hepatocellular carcinoma (HCC), used for diagnosis, outcome prediction, long-term follow-up, and treatment ...

(HealthDay News) — Measurement of α-fetoprotein (AFP) detects hepatocellular carcinoma (HCC) most accurately in patients without hepatitis C virus (HCV) infection, according to a study published in ...

EMERYVILLE, Calif.--(BUSINESS WIRE)--Eureka Therapeutics, Inc., a clinical-stage biotechnology company developing novel T cell therapies to treat solid tumors, today announced the publication of a ...